EN
CN
Home
About Us
Company
Development
Vision
Advantage
Leadership
Partnerships
Technology & Products
Science
Pipeline
Technology
News
Press Release
Media Report
Academic Papers
Careers
Careers
Contact
Home
About Us
Company
Development
Vision
Advantage
Leadership
Partnerships
Technology & Products
Science
Pipeline
Technology
News
Press Release
Media Report
Academic Papers
Careers
Careers
Contact
EN
CN
Using synthetic lethality strategy to target tumor cells with DNA damage repair defects
Science
Pipeline
Technology
Technology
Technology
Project Initiation
CRISPR Virtual Compound Screening
Lead Compound Search and Optimization
Cryoelectron Microscopy X-ray Diffraction HTRF qPCR
In Vivo Pharmacodynamic
Tumor Transplantation Flow Cytometry Immunohistochemistry
Translational Medicine
Tumor Cell Bank PDX
About Us
Technology & Products
News
Careers
Business Development
bd@synrx.cn
Careers
hr@synrx.cn
Address
@ Room 201, Building 4, 1390 Cangxing Street, Cangqian Subdistrict, Yuhang District, Hangzhou, Zhejiang
@ Room 303, No.1, Lane 88, Shengrong Road, Zhangjiang High-Tech Park, Pudong New District, Shanghai
0571-86360796
Contact
CopyRight 2022 All Right Reserved
SynRx Therapeutics
浙ICP备2021033925号
SiteMap
0571-86360796